MIM
ZY

MetLife Investment Management’s Zymergen Inc. Common Stock ZY Stock Holding History

MetLife Investment Management’s Portfolio ZY Stock Details ZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-18,226
Closed -$52.7K – 2935
2022
Q1 		$52.7K Sell
18,226
-13,659
-43% -$58K ﹤0.01% 2675
2021
Q4 		$213K Buy
31,885
+24,252
+318% +$236K ﹤0.01% 2016
2021
Q3 		$101K Hold
7,633
– – ﹤0.01% 2436
2021
Q2 		$305K Buy
+7,633
New +$301K ﹤0.01% 1874

Other funds holding ZY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TVPI
True Venture Partners IV Palo Alto, California $8.41M AUM 78.89% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DCI
Data Collective II Palo Alto, California $8.44M AUM 11.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSV
Two Sigma Ventures New York $9.61M AUM 58.41% 1-Year Est. Return

MetLife Investment Management's ZY Position: Q2 2022 in Review

MetLife Investment Management sold out of Zymergen Inc. Common Stock (ZY) in Q2 2022, closing a stake of 18,226 shares — an estimated $52.7K sold.

MetLife Investment Management first reported a position in ZY in Q2 2021 and held it in 4 quarters. The position peaked at $305K in Q2 2021. 81 funds tracked by Wall St. Rank hold ZY as of Q2 2022.

  • MetLife Investment Management reported no remaining Zymergen Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • MetLife Investment Management sold 18,226 Zymergen Inc. Common Stock shares in Q2 2022, an estimated $52.7K.
  • MetLife Investment Management first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 4 quarters.
  • MetLife Investment Management's Zymergen Inc. Common Stock position peaked at $305K in Q2 2021.
  • 81 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q2 2022.

Based on MetLife Investment Management's 13F filing for Q2 2022, filed 11 Aug 2022.